*AggelerP., and O'ReillyR.: Effects of Heptabarbital on the Response to Bishydroxycoumarin in Man, J. Lab. Clin. Med.74: 229, 1969.
2.
*AggelerP. M.: Potentiatión of Anticoagulant Effect of Warfarin by Phenylbutazone, N. Engl. J. Med.276: 469, 1967.
3.
AMA Council on Drugs: AMA Drug Evaluation, American Medical Association, Chicago, IL, 1970.
4.
*AntlitzA., and AwaitL.: A Double Blind Study of Acetaminophen Used in Conjunction with Oral Anticoagulant Therapy, Curr. Ther. Res.11: 360, 1969.
5.
*AntlitzA., MeadJ., and TolentinoM.: Potentiation of Oral Anticoagulant Therapy by Acetaminophen, Curr. Ther. Res.10: 501, 1968.
6.
AntonA.: The Effect of Disease, Drugs, and Dilution on the Binding of Sulfonamides in Human Plasma, Clin. Pharmacol. Ther.9: 561, 1968.
7.
BeckerG. L.: The Case Against Mineral Oil, J. Digestive Dis.19: 344, 1952.
8.
*Boston Collaborative Drug Surveillance Program: Interaction Between Chloral Hydrate and Warfarin, N. Engl. J. Med.286: 53, 1972.
9.
*BreckenridgeA., and OrmeM.: Clinical Implications of Enzyme Induction, Ann. N.Y. Acad. Sci.179: 421, 1971.
10.
BreckenridgeA., and OrmeM.: Drug Interactions with Warfarin: Studies with Dichlorophenazone, Chloral Hydrate and Phenazone (Antipyrine), Clin. Sci.40: 351, 1971.
11.
BrodieB.: Displacement of One Drug by Another From Carrier or Receptor Sites, Proc. Roy. Soc. Med.58: 946–955, 1965.
12.
CapizziR. L., BertinoJ. R., and HandschumacherR. E.: L-Asparaginase, Amer. Rev. Med.21: 433, 1970.
13.
*CarterS.: Potentiation of the Effect of Orally Administered Anticoagulants by Phenyramidol Hydrochloride, N. Engl. J. Med.273: 423, 1965.
14.
ChatterjeaJ.: Antagonistic Effect of A.C.T.H. and Cortisone on the Anticoagulant Activity of Ethyl Biscoumacetate, Brit. Med. J.2: 790–792, 1954.
15.
ChristensenL., and SkovstedL.: Inhibition of Drug Metabolism by Chloramphenicol, Lancet2: 1397, (Dec. 27) 1969.
16.
CoeR., and BullF. A.: Cirrhosis Associated with Methotrexate Treatment of Psoriasis, J. Amer. Med. Assoc.206: 1515, 1968.
17.
CoonW. W.: Anticoagulants and Drug Interaction, J. Univ. Mich. Med. Center33: 36, 1967.
18.
Council on Drugs: Evaluation of a New Antibacterial Agent—Cephaloridine (Loridine), J. Amer. Med. Assoc.206: 1289, 1968.
19.
CullenS. I., and CatalanoP. M.: Griseofulvin—Warfarin Antagonism, J. Amer. Med. Assoc.199: 150, 1967.
20.
DeykinD.: Warfarin Therapy (Part 2), N. Engl. J. Med.283: 801, 1970.
21.
EdwardsM. S., and CurtisJ. R.: Decreased Anticoagulant Tolerance with Oxymetholone, Lancet2: 221 (July 24) 1971.
22.
FleisherN.: Chronic Laxative-Induced Hyper-aldosteronism and Hypokalemia Simulating Bartter's Syndrome. Ann. Intern. Med.70: 791, 1969.
23.
FrickP. G.: Hemorrhagic Diathesis with Increased Capillary Fragility Caused by Salicylate Therapy, Amer. J. Med. Sci.231: 402, 1956.
24.
*GarrettsonL., PerelJ. M., and DaytonP. G.: Methylphenidate Interaction with Both Anticonvulsants and Ethyl Bisconmacetate, J. Amer. Med. Assoc.207: 2053, 1969.
25.
GilbertD.: Hypoprothrombinemia as a Complication of Propylthiouracil, J. Amer. Med. Assoc.189: 855, 1964.
26.
GoodmanL. S., and GilmanA. (Eds.): The Pharmacological Basis of Therapeutics, 4th Ed., Macmillan, N.Y., 1970.
27.
*GossJ. E., and DickhausD.: Increased Bishydroxycoumarin Requirements in Patients Receiving Phenobarbital, N. Engl. J. Med.273: 1094, 1965.
28.
*GouldL.: Prothrombin Levels Maintained with Meprobamate and Warfarin, J. Amer. Med. Assoc.220: 1460, 1972.
29.
GreenJ., EdwinE. E., DiplockA. T., and BunyanJ.: Effect of a Water Soluble Metabolite of a-Tocopherol on Ubiquinone in the Rat, Biochem. Biophys. Acta49: 417, 1961.
30.
Hampton: Platelet Behaviour & Drugs Used in Cardiovascular Disease, Cardiosvascular Res.1: 101, 1967.
31.
HansenJ. M., KristensenM., and ChristensenL. K.: Dicoumarol-Induced Diphenylhydantoin Intoxication, Lancet2: 265–266, (July 30) 1966.
32.
HansenM. J., Sicrsboek-NiclsenK., and SkovstedL.: Carbamazepine-Induced Acceleration of Diphenylhydantoin and Warfarin Metabolism in Man, Clin. Pharmacol. Ther.12: 539, 1971.
33.
HanstenP. D.: Hosp. Formul. Manage.4: 20, 1969.
34.
*HolcenbergJ., BidgoodM., and DixonR.: Studies of the Possible Therapeutic Interaction Between Cyclamate and Warfarin, Curr. Ther. Res.11: 577, 1969.
35.
HrdinaP., and KovalcikV.: Effect of Reserpine and Some Adrenolytics on the Anticoagulant Activity of Peletan (Ethylbiscoumacetate), Throm. Diath. Haemmorrh.18: 759, 1967.
36.
HumeR., StoneJ., and WeyersE.: Interaction of Ascorbic Acid and Warfarin, J. Amer. Med. Assoc.219: 1479, 1972.
37.
*KaterR. M. H.: Increased Rate of Clearance of Drugs from the Circulation of Alcoholics, Amer. J. Med. Sci.258: 35, 1969.
38.
Klippel, and PitsingerB.: Hypoprothrombinemia Secondary to Antibiotic Therapy and Manifested by Massive Gastro-Intestinal Hemorrhage, Arch. Surg.96: 266, 1968.
39.
Koch-WeserJ.: Quinidine-Induced Hypoprothrombinemic Hemorrhage in Patients on Chronic Warfarin Therapy, Ann. Intern. Med.68: 511, 1968.
40.
Koch-WeserJ.: Potentiation by Glucagon of the Hypoprothrombinemic Action of Warfarin, Ann. Intern. Med.72: 331, 1970.
41.
KristensenM., and HansenJ. M.: Potentiation of the Tolbutamide Effect by Dicoumarol, Diabetes16: 211, 1967.
42.
*KristensenM., and HansenJ. M.: Accumulation of Chlorpropamide Caused by Dicoumarol, Acta Med. Scand.185: 83, 1968.
43.
*LacknerH., and HuntV. E.: The Effect of Librium on Hemostasis, Amer. J. Med. Sci.256: 368, 1968.
44.
LewisR. J.: Effect of Barbiturates on Anticoagulant Therapy, N. Engl. J. Med.274: 110, 1966.
45.
LubranM.: The Effects of Drugs on Laboratory Values, Med. Clin. N. Amer.53: 211, 1969.
46.
*MacDonaldM., and RobinsonD.: Clinical Observations of Possible Barbiturate Interference with Anticoagulation, J. Amer. Med. Assoc.204: 95, 1968.
47.
*MacDonaldM., RobinsonD., SylwesterD., and JaffeJ.: The Effects of Phenobarbital, Chloral Betaine, and Glutethimide Administration on Warfarin Plasma Levels and Hypoprothrombinemic Responses in Man, Clin. Pharmacol. Ther.10: 80, 1969.
48.
Martin: Hemorrhagic Diathesis Induced by Antimicrobials, J. Amer. Med. Assoc.205: 192, 1968.
49.
*MenczelJ., and DreyfusF.: Effect of Prednisone on Blood Coagulation Time in Patients on Dicumarol Therapy, J. Lab. Clin. Med.56: 14, 1960.
50.
MillsD., and RobertsG.: Membrane Active Drugs and the Aggregation of Human Blood Platelets, Nature (London)213: 35–38, 1967.
51.
*MoserK. M., and HajjarG. C.: Effect of Heparin on the One-Stage Prothrombin Time, Ann. Intern. Med.66: 1207, 1967.
52.
*MurakamiM..: Effects of Anabolic Steroids on Anticoagulant Requirements, Jap. Circ. J.29: 243, 1965.
53.
OakleyD. P., and LautchH.: Haloperidol and Anticoagulant Treatment, Lancet2: 1232 (Dec. 7) 1963.
54.
OgstonD., and DouglasA. S.: Anticoagulant and Thrombolytic Drugs—II. Clinical Aspects, Drugs (Basel)1: 301, 1971.
55.
O'ReillyR., and AggelerP.: Determinants of the Response to Oral Anticoagulant Drugs in Man, Pharmacol. Rev.22: 35, 1970.
56.
*OrmeM., BreckenridgeA., and BrooksR. V.: Interactions of Benzodiazepines with Warfarin, Brit. Med. J.3: 611, 1972.
57.
Physicians Desk Reference, Medical Economics, Inc., Oradell, N.J., 1969.
58.
*RobinsonB. H. B., HawkinsJ. B., EllisJ. B., RobinsonM.: Decreased Anticoagulant Tolerance with Oxymetholone, Lancet2: 1356 (June 26) 1971.
59.
RobinsonD., BenjaminD., and McCormickJ.: Interaction of Warfarin and Non-Systemic Gastrointestinal Drugs, Clin. Pharmacol. Ther.12: 491, 1971.
60.
RobinsonD., and SylwesterD.: Interaction of Commonly Prescribed Drugs and Warfarin, Ann. Intern. Med.72: 853, 1970.
61.
RosenthalGeorge: Case Report: Interaction of Ascorbic Acid and Warfarin, J. Amer. Med. Assoc.215: 1671, 1971.
62.
RothsteinE.: Warfarin Effect Enhanced by Disulfiram, J. Amer. Med. Assoc.206: 1574, 1968.
63.
*SalzmanE. W., HarrisW. H., and DeSanchsR.: Reduction in Venous Thromboembolism by Agents Affecting Platelet Function, N. Engl. J. Med.284: 1287, June 10, 1971.
64.
SalzmanE. W.: Cyclic Amp and Platelet Function, N. Engl. J. Med.286: 358, 1972.
65.
*SchrogieJ., and SolomonH.: The Anticoagulant Response to Bishydroxycoumarin, II. The Effect of D-Thyroxine, Clofibrate, and Norethandrolone, Clin. Pharmacol. Ther.8: 70, 1967.
66.
*SchrogieJ.: Effect of Oral Contraceptives on Vitamin K Dependent Clotting Activity, Clin. Pharmacol. Ther.8: 670, 1967.
SellersE., and Koch-WeserJ.: Displacement of Warfarin from Human Albumin by Diazoxide and Ethacrynic, Mefenamic, and Nalidixic Acids, Clin. Pharmacol. Ther.11: 524, 1970.
69.
*SellersE., and Koch, WeserJ.: Kinetics and Clinical Importance of Displacement of Warfarin from Albumin by Acidic Drugs, Ann. N.Y. Acad. Sci.179: 213, 1971.
70.
SellersE. M., LangM. I., and Koch-WeserJ.: Potentiation by Trichloroethylphosphate of Warfarin-Induced Hypoprothrombinemia, Clin. Pharmacol. Ther.13: 152, 1972.
71.
SigellL. T., and FlessaH. C.: Drug Interactions with Anticoagulants, J. Amer. Med. Assoc.214: 2035, 1970.
72.
SilvermanJ. L., and WurzelH. A.: The Effect of Glyceryl Guaiacolate on Platelet Function and Other Coagulation Factors In Vitro, Amer. J. Clin. Pathol.51: 35, 1969.
73.
SolomonH., BarakatM., and AshleyC.: Mechanisms of Drug Interaction, J. Amer. Med. Assoc.216: 1997, 1971.
74.
StarziT. E.: Cyclophosphamide and Whole Organ Transplantation in Human Beings, Surg. Gynecol. Obstet.133: 981, 1971.
75.
SteinH., and HilgartnerM.: Alteration of Coagulation Mechanisms of Blood by Contrast Media, Amer. J. Roentgenol.104: 458, 1968.
76.
StuartD. M.: Pharmindex, 1968.
77.
*SutorA., BowieW., and OwenC.: Effects of Aspirin, Sodium Salicylate, and Acetaminophen on Bleeding, Mayo Clin. Proc.46: 178, 1971.
78.
*UdallJ.: Drug Interference with Warfarin Therapy, Clin. Med.78: 20, 1970.
79.
UdallJ.: Warfarin Therapy Not Influenced by Meprobamate: A Controlled Study in Nine Men, Curr. Ther. Res.12: 724, 1970.
80.
Upjohn Package Insert on Dipaxin.
81.
VcssellE. S., PassanantiT., and GreeneF. E.: Impairment of Drug Metabolism in Man by Allopurinol and Nortriptyline, N. Engl. J. Med.283: 1484, 1970.
82.
WeinerM.: Effect of Centrally Active Drugs on the Action of Coumarin Anticoagulants, Nature212: 1599, 1966.
83.
ZuckerM. B., and PetersonJ.: Inhibition of Adenosine Diphosphate-Induced Secondary Aggregation and Other Platelet Functions by Acetylsalicylic Acid, Proc. Soc. Exp. Biol. Med.127: 547–551, 1968.
84.
ZuckerM. B., and PetersonJ.: Effects of Acetylsalicylic Acid, Other Non-steroidal Anti-inflammatory Agents and Dipyridamole on Human Blood Platelets, J. Lab. Clin. Med.76: 66, 1970.
